The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

Scientists use light 10 billion times stronger than the sun to find potential Ebola weakspot

There is currently no vaccine or cure for Ebola, which killed thousands of people during an outbreak in West Africa

Ian Johnston
Science Correspondent
Wednesday 29 June 2016 18:02
Comments
As big as Wembley, Diamond Light Source has put Britain at the forefront of pioneering research
As big as Wembley, Diamond Light Source has put Britain at the forefront of pioneering research

A light 10 billion times brighter than the sun has been used to discover the molecular structure of Ebola virus – in a major step towards the creation of a vaccine against the deadly disease, researchers have said.

It is thought the Diamond Light Source in Oxfordshire – housed in a building the size of Wembley stadium – could expose the Achilles’ heel of many currently untreatable diseases, such as drug-resistant superbugs, by examining them at the atomic scale.

When researchers from Oxford University turned it on the Ebola virus they were able to work out its structure.

Scientists had already identified two existing drugs, the painkiller ibuprofen and anti-cancer drug toremifene, which might have an effect on the virus.

So the Oxford team also used the light on Ebola after it had been treated with the two drugs and discovered that they were able to inhibit its spread to a degree.

Professor Dave Stuart, who led the study, said: “This information can guide the design of more powerful anti-Ebola drugs. My group will be continuing this project at Diamond … which should help us to further accelerate the rational drug design process.

“We hope this research will lead to new drugs that can help to save lives if we are faced with further outbreaks of the disease in the future.”

He previously used the light to examine the foot-and-mouth virus, in research that helped to develop new vaccines against it.

The researchers, whose findings were published in the journal Nature, looked at existing drugs because they have already been through the clinical trial process, demonstrating they are safe for use on human patients.

This means they could be used to treat Ebola patients more quickly than if a new drug had to be created from scratch.

The outbreak of Ebola in West Africa killed more than 11,000 people before a massive global response helped stop it from spreading.

However there are currently no vaccines to prevent people getting it or effective therapeutic drugs.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in